This is a non-core endpoint: only basic statistics are computed.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
22 |
4. Check minimum number of events
Min. number of events
3
|
22 |
5. Include endpointsNone |
22 |
6. Filter based on genotype QC (FinnGen only) |
22 |
Control definitions (FinnGen only)
- Control exclude
- RX_NSAID
Extra metadata
- First used in FinnGen datafreeze
- DF4
Similar endpoints
↥List of similar endpoints to
Butylpyrazolidines
based on the number of shared cases.
Similar with more cases:
- Anti-inflammatory and antirheumatic products, non-steroids
- Paracetamol or NSAID medication
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 22 | 8 | 14 |
| Unadjusted period prevalence (%) | 0.01 | 0.00 | 0.01 |
| Median age at first event (years) | 46.95 | 41.83 | 49.88 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
No data available
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
12
75
2.32
1.03
2.0
2.1
—
—
—
0
0
16
117
2.34
0.94
4.3
3.2
15.00
15.44
pmol/l
0.32
16
104
12
84
1.94
0.69
6.1
7.5
1.22
1.20
mmol/l
0.30
12
78
10
73
1.68
0.45
2.5
2.4
—
—
—
0
0
0
15
0.00
0.43
0.0
10.7
—
24.97
—
0
15
0
18
0.00
0.42
0.0
1.3
—
—
—
0
0
12
97
1.52
0.32
7.5
9.2
1.21
1.20
mmol/l
0.08
12
82
5
37
1.45
0.26
2.8
3.3
12.00
2150.53
ng/l
—
5
30
0
10
0.00
0.22
0.0
1.0
—
—
—
0
0
6
68
0.84
0.09
5.5
3.1
—
—
—
0
0
7
67
1.07
-0.00
1.9
2.8
90.00
73.80
nmol/l
—
7
60
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
5
50
1.00
-0.00
2.4
1.5
1.46
1.33
mmol/l
—
5
41
5
56
0.86
-0.00
4.0
5.7
—
—
—
0
0
0
8
0.00
-0.00
0.0
7.5
—
24.47
—
0
8
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: RX_BUTYLPYRA – Butylpyrazolidines
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).